Enhanced protective efficacy against Mycobacterium tuberculosis afforded by BCG prime-DNA boost regimen in an early challenge mouse model is associated with increased splenic interleukin-2-producing CD4 T-cell frequency post-vaccination (Q42210000)
Jump to navigation
Jump to search
scientific article published on December 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Enhanced protective efficacy against Mycobacterium tuberculosis afforded by BCG prime-DNA boost regimen in an early challenge mouse model is associated with increased splenic interleukin-2-producing CD4 T-cell frequency post-vaccination |
scientific article published on December 2014 |
Statements
1 reference
Enhanced protective efficacy against Mycobacterium tuberculosis afforded by BCG prime-DNA boost regimen in an early challenge mouse model is associated with increased splenic interleukin-2-producing CD4 T-cell frequency post-vaccination (English)
1 reference
Han Kang
Hui Ma
De-Ping Han
Kang Wu
Douglas B Lowrie
1 December 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference